These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A synthetic peptide corresponding to glycoprotein hormone alpha subunit residues 32-46 inhibits gonadotropin binding to receptor. Leng N; Grasso P; Deziel MR; Reichert LE Pept Res; 1995; 8(5):272-7. PubMed ID: 8589549 [TBL] [Abstract][Full Text] [Related]
3. D-amino acid substitution of residues 32 to 46 of the glycoprotein hormone common alpha-subunit: development of a synthetic glycoprotein hormone antagonist. Leng N; Grasso P; Reichert LE Pept Res; 1996; 9(4):188-94. PubMed ID: 8914166 [TBL] [Abstract][Full Text] [Related]
4. The role of subunit sialic acid in the thyrotropic and gonadotropic activities of human chorionic gonadotropin. Amir SM; Kasagi K; Ingbar SH Endocrinology; 1987 Jul; 121(1):160-6. PubMed ID: 3036467 [TBL] [Abstract][Full Text] [Related]
5. Design of a long-lived thyrotropin antagonist from derivatives of human chorionic gonadotropin. Hoermann R; Amir SM; Nomura T; Ingbar SH Endocrinology; 1989 Jan; 124(1):223-32. PubMed ID: 2462487 [TBL] [Abstract][Full Text] [Related]
6. The effects of synthetic alpha-subunit peptides on thyrotropin interaction with its receptor. Morris JC; Jiang NS; Charlesworth MC; McCormick DJ; Ryan RJ Endocrinology; 1988 Jul; 123(1):456-62. PubMed ID: 3383781 [TBL] [Abstract][Full Text] [Related]
7. Structure-function studies of the human thyrotropin receptor. Inhibition of binding of labeled thyrotropin (TSH) by synthetic human TSH receptor peptides. Morris JC; Bergert ER; McCormick DJ J Biol Chem; 1993 May; 268(15):10900-5. PubMed ID: 8496155 [TBL] [Abstract][Full Text] [Related]
8. Site-directed mutagenesis of amino acids 33-44 of the common alpha-subunit reveals different structural requirements for heterodimer expression among the glycoprotein hormones and suggests that cyclic adenosine 3',5'-monophosphate production and growth promotion are potentially dissociable functions of human thyrotropin. Grossmann M; Szkudlinski MW; Dias JA; Xia H; Wong R; Puett D; Weintraub BD Mol Endocrinol; 1996 Jun; 10(6):769-79. PubMed ID: 8776737 [TBL] [Abstract][Full Text] [Related]
9. Asialoagalacto-human chorionic gonadotropin, a carbohydrate-modified variant of human chorionic gonadotropin, antagonizes the stimulatory actions of bovine thyroid-stimulating hormone on thyroid function and HLA-DR expression in human thyroid in vitro and in vivo. Hoermann R; Schumm-Draeger PM; Rehbach K; Mann K J Clin Invest; 1991 Dec; 88(6):1947-54. PubMed ID: 1752954 [TBL] [Abstract][Full Text] [Related]
10. Contribution of specific amino acid residues within the hFSH alpha 26-46 sequence region to FSH receptor-binding activity. Cattini-Schultz SV; Stanton PG; Robertson DM; Hearn MT Pept Res; 1995; 8(4):214-26. PubMed ID: 8527875 [TBL] [Abstract][Full Text] [Related]
11. Specificity of cognate ligand-receptor interactions: fusion proteins of human chorionic gonadotropin and the heptahelical receptors for human luteinizing hormone, thyroid-stimulating hormone, and follicle-stimulating hormone. Schubert RL; Narayan P; Puett D Endocrinology; 2003 Jan; 144(1):129-37. PubMed ID: 12488338 [TBL] [Abstract][Full Text] [Related]
12. Evidence that partially desialylated variants of human chorionic gonadotropin (hCG) are the factors in crude hCG that inhibit the response to thyrotropin in human thyroid membranes. Hoermann R; Amir SM; Ingbar SH Endocrinology; 1988 Sep; 123(3):1535-43. PubMed ID: 3402396 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of TSH bio-activity by synthetic beta TSH peptides. Freeman SL; McCormick DJ; Ryan RJ; Morris JC Endocr Res; 1992; 18(1):1-17. PubMed ID: 1315679 [TBL] [Abstract][Full Text] [Related]
14. Peptide sequences from the hypervariable regions of two monoclonal anti-idiotypic antibodies against the thyrotropin (TSH) receptor are similar to TSH and inhibit TSH-increased cAMP production in FRTL-5 thyroid cells. Taub R; Hsu JC; Garsky VM; Hill BL; Erlanger BF; Kohn LD J Biol Chem; 1992 Mar; 267(9):5977-84. PubMed ID: 1313425 [TBL] [Abstract][Full Text] [Related]
15. Chimeric proteins can exceed the sum of their parts: implications for evolution and protein design. Campbell RK; Bergert ER; Wang Y; Morris JC; Moyle WR Nat Biotechnol; 1997 May; 15(5):439-43. PubMed ID: 9131622 [TBL] [Abstract][Full Text] [Related]
16. [Peptide 612-627 of thyrotropin receptor and its modified derivatives as the regulators of adenylyl cyclase in the rat thyroid gland]. Shpakov AO; Shpakova EA; Tarasenko II; Derkach KV Tsitologiia; 2014; 56(7):526-35. PubMed ID: 25696997 [TBL] [Abstract][Full Text] [Related]
17. Co-evolution of ligand-receptor pairs. Moyle WR; Campbell RK; Myers RV; Bernard MP; Han Y; Wang X Nature; 1994 Mar; 368(6468):251-5. PubMed ID: 8145825 [TBL] [Abstract][Full Text] [Related]
18. Presence of a putative steroidal allosteric site on glycoprotein hormone receptors. Rossi M; Dimida A; Ferrarini E; Silvano E; De Marco G; Agretti P; Aloisi G; Simoncini T; Di Bari L; Tonacchera M; Giorgi F; Maggio R Eur J Pharmacol; 2009 Nov; 623(1-3):155-9. PubMed ID: 19766106 [TBL] [Abstract][Full Text] [Related]
19. Antagonists of the human TSH receptor: in vitro and in vivo studies of their functional and immunological effects. Hoermann R; Schumm-Draeger PM; Mann K Exp Clin Endocrinol; 1992; 100(1-2):36-40. PubMed ID: 1468513 [TBL] [Abstract][Full Text] [Related]
20. The role of the oligosaccharide chains of thyrotropin alpha- and beta-subunits in hormone action. Thotakura NR; Desai RK; Szkudlinski MW; Weintraub BD Endocrinology; 1992 Jul; 131(1):82-8. PubMed ID: 1377127 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]